SYNOPSYS INC (SNPS) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2017 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Synopsys Inc quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from 2017 to 2023.
  • Synopsys Inc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending January 31, 2024 was -$320 M, a 21.9% decline year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Trailing 12 Months (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$320 M -$57.4 M -21.9% Nov 1, 2023 Jan 31, 2024 10-Q 2024-02-23
Q3 2023 $21.3 M +$36.6 M Nov 1, 2022 Oct 31, 2023 10-K 2023-12-12
Q4 2022 -$263 M +$46 M +14.9% Nov 1, 2022 Jan 31, 2023 10-Q 2024-02-23
Q3 2022 -$15.3 M -$213 M -108% Nov 1, 2021 Oct 31, 2022 10-K 2023-12-12
Q4 2021 -$309 M -$96 M -45.2% Nov 1, 2021 Jan 31, 2022 10-Q 2023-02-17
Q3 2021 $197 M -$310 M -61.1% Nov 1, 2020 Oct 31, 2021 10-K 2023-12-12
Q4 2020 -$213 M -$184 M -653% Nov 1, 2020 Jan 31, 2021 10-Q 2022-02-18
Q3 2020 $507 M +$502 M +9083% Nov 1, 2019 Oct 31, 2020 10-K 2022-12-12
Q4 2019 -$28.2 M +$103 M +78.4% Nov 1, 2019 Jan 31, 2020 10-Q 2021-02-19
Q3 2019 $5.53 M +$331 M Nov 1, 2018 Oct 31, 2019 10-K 2021-12-13
Q4 2018 -$131 M +$311 M +70.4% Nov 1, 2018 Jan 31, 2019 10-Q 2020-02-21
Q3 2018 -$325 M -$395 M -567% Nov 1, 2017 Oct 31, 2018 10-K 2020-12-15
Q4 2017 -$442 M Nov 1, 2017 Jan 31, 2018 10-Q 2019-02-25
Q3 2017 $69.7 M Nov 1, 2016 Oct 31, 2017 10-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.